Bone marrow plasmacytosis in multiple myeloma is characteristically more than: September 2011
**Core Concept:** Multiple myeloma is a plasma cell neoplasm characterized by the clonal proliferation of plasma cells in the bone marrow, leading to dysregulated protein production, bone lesions, and renal impairment. Bone marrow plasmacytosis is a hallmark feature of multiple myeloma.
**Why the Correct Answer is Right:** Plasmacytosis is the excessive proliferation of plasma cells in the bone marrow. In multiple myeloma, the number of plasma cells exceeds 10% or reaches or exceeds 20% in the bone marrow. This increased plasma cell population leads to the production of monoclonal proteins, which can cause complications like renal impairment, osteolytic lesions, and hypercalcemia.
**Why Each Wrong Option is Incorrect:**
A. 10% is not a specific threshold for plasmacytosis and does not exclusively apply to multiple myeloma.
B. The statement "less than or equal to 20%" is incorrect, as the correct threshold is "exceeds or reaches 20%".
C. A value of "less than 10%" is too low to be considered as plasmacytosis in the context of multiple myeloma.
D. Although plasmacytosis can be observed in other disorders like monoclonal gammopathy of undetermined significance (MGUS) and Waldenström's macroglobulinemia, the correct answer should specifically refer to multiple myeloma as per the question.
**Clinical Pearl:** The correct threshold for bone marrow plasmacytosis in multiple myeloma is "exceeds or reaches 20%". This threshold helps differentiate multiple myeloma from other disorders with plasmacytosis like MGUS and Waldenström's macroglobulinemia, as these conditions typically have lower plasmacytosis values.
**Correct Answer:** .